(S)-4-(Chloromethyl)-2,2-dimethyl-1,3-dioxolane, 95.0%, 5g

15-Bromo-1-pentadecanol, 95.0%, 1g

ethyl (1S,2S)-rel-2-(4-ethoxy-3-fluorophenyl)cyclopropane-1-carboxylate, 97.0%, 10g

3-(Trimethoxysilyl)propyl Methacrylate (stabilized with BHT)>98.0%(GC)25mL

(3-Amino-1H-pyrazol-5-yl)methanol, 95.0%, 250mg

10-Acetylphenothiazine>98.0%(GC)5g

(R)-4-Chloro-2,3-dihydro-1H-inden-1-amine hydrochloride, 95.0%, 1g

Fmoc-3-Nitro-tyrosine, >99%, 10g

5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-N-(prop-2-yn-1-yl)pentanamide, 95+%, 1g

(4-Bromo-1-methyl-1H-1,2,3-triazol-5-yl)methanol, 98%, 5g

(S)-10-Benzyl-23-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-6,9,12,15,18-pentaoxo-3-oxa-5,8,11,14,17-pentaazatricosan-1-oic acid, 95%, 100mg

Aniline, min. 99%, for synthesis, 2.5 l, glass packaging

N-Boc-2-Propargyl-L-glycine, 95.0%, 5g